Decrypting the Possible Mechanistic Role of Fenofibrate in Alzheimer's Disease and Type 2 Diabetes: The Truth and Mystery
Journal of Cellular and Molecular Medicine · 2025
DOI: 10.1111/jcmm.70378 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Cellular and Molecular Medicine, 2025. Verfasst von Mansour A Alsaleem und 9 weiteren Autor:innen. Beteiligte Einrichtung: Unit of Scientific Research, Applied College, Qassim University, Buraydah, Saudi Arabia. Hauptthemen laut MEDLINE: Fenofibrate, Alzheimer Disease, Diabetes Mellitus, Type 2. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 257 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The University of Witten-Herdecke Germany.
Themen: Diabetes mellitus, Demenz
Abstract (Originalsprache)
Alzheimer's disease (AD) is a neurodegenerative disease caused by the progressive deposition of extracellular amyloid beta (Aβ) and intracellular neurofibrillary tangles (NFTs). Of note, metabolic disorders such as insulin resistance (IR) and type 2 diabetes (T2D) are associated with the development of brain IR and associated neurodegeneration. In addition, AD neuropathology and linked cognitive impairment accelerate the development of peripheral IR and the progression of T2D. Therefore, there is a bidirectional relationship between T2D and AD. It has been demonstrated that AD and T2D induce dysregulation of peroxisome proliferator‐activated receptor alpha (PPAR‐α) leading to the central and peripheral metabolic disturbances. Hence, dysregulated PPAR‐α could be a shared mechanism in both AD and T2D, and restoration of PPAR‐α signalling by PPAR‐α agonist fenofibrate (FN) may alleviate T2D and AD. Therefore, this review aims to shed light on the potential involvement of PPAR‐α in T2D and AD, and how FN could be effective in the management of AD. FN seems to be effective in both AD and T2D by dual neuroprotective and antidiabetic effects that can mitigate AD neuropathology and T2D‐related complications by modulating various cellular processes and inflammatory signalling pathways. In conclusion, FN could be a possible candidate in the management of AD and T2D by modulating different signalling pathways involved in the pathogenesis of these conditions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Unit of Scientific Research, Applied College, Qassim University, Buraydah, Saudi Arabia.
- Department of Clinical Pharmacology and Medicine, College of Medicine, Mustansiriyah University, Baghdad, Iraq.
- Department of Clinical Pharmacology, Jabir Ibn Hayyan Medical University, Kufa, Iraq.
- Department of Pharmacology and Toxicology, Faculty of Pharmacy, Beni-Suef University, Beni-Suef, Egypt.
- Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, Shaqra University, Shaqra, Saudi Arabia.
- Department of Clinical Pharmacology, College of Dentistry, Al-Rasheed University, Baghdad, Iraq.
ORCID-Profile: Maha M Abdel-Fattah, Marios Papadakis, Gaber El-Saber Batiha
Förderung
- The University of Witten-Herdecke Germany
Zitieren
APA
Alsaleem, M. A., Al-Kuraishy, H. M., Al-Gareeb, A. I., Abdel-Fattah, M. M., Alrouji, M., Al-Harchan, N. A., Alruwaili, M., Papadakis, M., Alexiou, A., & Batiha, G. E. (2025). Decrypting the Possible Mechanistic Role of Fenofibrate in Alzheimer's Disease and Type 2 Diabetes: The Truth and Mystery. Journal of Cellular and Molecular Medicine. https://doi.org/10.1111/jcmm.70378
Vancouver
Alsaleem MA, Al-Kuraishy HM, Al-Gareeb AI, Abdel-Fattah MM, Alrouji M, Al-Harchan NA, et al. Decrypting the Possible Mechanistic Role of Fenofibrate in Alzheimer's Disease and Type 2 Diabetes: The Truth and Mystery. Journal of Cellular and Molecular Medicine. 2025. doi:10.1111/jcmm.70378
BibTeX
@article{Alsaleem2025,
author = {Alsaleem, Mansour A and Al-Kuraishy, Hayder M and Al-Gareeb, Ali I and Abdel-Fattah, Maha M and Alrouji, Mohammed and Al-Harchan, Nasser A and Alruwaili, Mubarak and Papadakis, Marios and Alexiou, Athanasios and Batiha, Gaber El-Saber},
title = {Decrypting the Possible Mechanistic Role of Fenofibrate in Alzheimer's Disease and Type 2 Diabetes: The Truth and Mystery},
journal = {Journal of Cellular and Molecular Medicine},
year = {2025},
doi = {10.1111/jcmm.70378}
}
EUVIMED